CALGARY, Alberta, April 13 (Reuters) - Lorus Therapeutics Inc does not have the cash it needs to meet a debt obligation due in October, the Canadian biotech company said on Monday as it reported a third-quarter loss.
CALGARY, Alberta, April 13 (Reuters) - Lorus Therapeutics Inc does not have the cash it needs to meet a debt obligation due in October, the Canadian biotech company said on Monday as it reported a third-quarter loss.